The MultiCare Neuroscience Center of Washington has been active in the search for new and innovative treatments for many of the devastating neurologic diseases that affect our community. The MultiCare Research Institute has partnered with the MultiCare Neuroscience Center of Washington to provide research opportunities to our community in many areas of neurologic science including:
John Huddlestone, MD and the site are nationally recognized for excellence. He has been involved in clinical trials for more then 2 decades. Trials are conducted at South Sound’s only nationally recognized Multiple Sclerosis Center. The site has participated in trials evaluating
Post-Herpetic Neuralgia pain control
Restless Leg Syndrome control of symptoms
Migraine Headache treatment and suppression
Movement Disorders treatment
The Investigators in Neuroscience medicine include:
Laura Hershkowitz, DO, FACN (Principal Investigator)
John Huddlestone, MD, FAAN (Principal Investigator)
Study Number: ACTH-MS Fatigue—The effect of ACTH (Acthar®) on measures of fatigue in patients with relapsing multiple sclerosis.
Ocrelizumab in patients with relapsing remitting multiple sclerosis who have had a suboptimal response to an adequate course of disease-modifying treatment.Study Info
outcomes of prophylactic therapies in migraine.Principal Investigator(s): John Huddlestone, MD, FAAN
characterize real-world clinical outcomes in patients with relapsing-remitting multiple sclerosis treated with disease-midifying therapies (Tecfidera,
Copaxone, Aubagio or Gilenya) (EFFECT).
A0081105—A randomized, double-blind, placebo-controlled, parallel group,
multicenter trial of Pregabalin as adjunctive therapy in pediatric and adult subjects with primary generalized tonic-clonic seizures.